Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
BY admin
April 16, 2025
0
Comments
137 Views
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.